packageAldesleukin

aldesleukin

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Aldesleukin, a form of interleukin-2, is an immunostimulant used to treat cancers such as melanoma and kidney-related malignancies, and has also been studied for other conditions including HIV infection. It is an approved medicine, mainly used in specialist cancer care, and carries a boxed warning reflecting its significant toxicity.

Summary written by glm-5.3-flash from Wikidata Q20801763 and the WHO ATC classification; not checked by a person.

name:aldesleukin
ATC codes:L03AC01
DrugBank:DB00041
Wikidata:Q20801763
molar mass:15314.8 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown